Catalysts for Sustained Therapeutics Inc
23 tracked
Apr 27, 2026
phase 2 completion
Sustained Therapeutics Inc — lidocaine SR (Phase II Trial Completion)
LIDOCAINE
→
Mar 24, 2026
device pma
Merz North America, Inc. — P050052 RADIESSE® Injectable Implant; RADIESSE® Hands; RADIESSE® (+) Lidocaine; Jawline indication (PMA supplement)
Sustained Therapeutics Inc
→
Mar 11, 2026
recall
HTO Nevada Inc. dba Kirkman recall (Cls II)
Sustained Therapeutics Inc
→
Mar 11, 2026
recall
HTO Nevada Inc. dba Kirkman recall (Cls II)
Sustained Therapeutics Inc
→
Feb 18, 2026
recall
Pro Numb Tattoo Numbing Spray LLC recall (Cls II)
Sustained Therapeutics Inc
→
Feb 18, 2026
recall
Pro Numb Tattoo Numbing Spray LLC recall (Cls II)
Sustained Therapeutics Inc
→
Feb 5, 2026
device pma
Q-Med AB — Restylane Lyft with Lidocaine (PMA supplement)
Sustained Therapeutics Inc
→
Jan 29, 2026
device pma
Q-Med AB — Restylane®-L 1 mL; Restylane® Lyft with Lidocaine 1 mL; Restylane® Eyelight 0.5 mL (PMA supplement)
Sustained Therapeutics Inc
→
Jan 13, 2026
device pma
Merz North America, Inc. — RADIESSE® Injectable Implant, RADIESSE® Hands, RADIESSE® (+) Lidocaine, Jawline indication (PMA supplement)
Sustained Therapeutics Inc
→
Dec 23, 2025
device pma
Q-Med AB — Restylane® Lyft with Lidocaine (PMA supplement)
Sustained Therapeutics Inc
→
Nov 4, 2025
device pma
Q-Med AB — Restylane® Lyft with Lidocaine (PMA supplement)
Sustained Therapeutics Inc
→
Oct 24, 2025
device pma
Merz North America, Inc. — Belotero Balance (+) Lidocaine Dermal Filler (PMA supplement)
Sustained Therapeutics Inc
→
Oct 10, 2025
device pma
Merz North America, Inc. — Belotero Balance (+) Lidocaine Dermal Filler (PMA supplement)
Sustained Therapeutics Inc
→
Oct 6, 2025
approval
LIDOCAINE — FDA approval
Sustained Therapeutics Inc
→
Sep 24, 2025
approval
BONDLIDO (LIDOCAINE) — FDA approval
Sustained Therapeutics Inc
→
Jul 14, 2025
device pma
Merz North America, Inc. — RADIESSE (+) Lidocaine (PMA supplement)
Sustained Therapeutics Inc
→
Jul 9, 2025
recall
Tailstorm Health INC recall (Cls II)
Sustained Therapeutics Inc
→
Jul 9, 2025
recall
Tailstorm Health INC recall (Cls II)
Sustained Therapeutics Inc
→
Jun 26, 2025
device pma
Merz North America, Inc. — RADIESSE® Injectable Implant, RADIESSE® Hands, RADIESSE® (+) Lidocaine, RADIESSE® (+) Jawline (PMA supplement)
Sustained Therapeutics Inc
→
Jun 16, 2025
device pma
Merz North America, Inc. — RADIESSE® Injectable Implant, RADIESSE® Hands, RADIESSE® (+) Lidocaine, RADIESSE® (+) Jawline (PMA supplement)
Sustained Therapeutics Inc
→
Jun 10, 2025
device pma
Merz North America, Inc. — RADIESSE® Injectable Implant, RADIESSE® Hands, RADIESSE® (+) Lidocaine, Jawline indication (PMA supplement)
Sustained Therapeutics Inc
→
Dec 4, 2024
recall
Unexo Life Sciences Private Limited recall (Cls II)
Sustained Therapeutics Inc
→
Oct 17, 2024
device 510k
Imbed Biosciences — Microlyte Ag/Lidocaine (510k cleared)
Sustained Therapeutics Inc
→